Literature DB >> 10980326

Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity.

U W Preuss1, M Soyka, M Bahlmann, K Wenzel, S Behrens, S de Jonge, M Krüger, B Bondy.   

Abstract

The aim of this study was to investigate [3H]paroxetine binding and impulsivity in alcohol-dependent and age-matched control subjects in relation to a 5'-promoter region serotonin transporter (5-HTT) polymorphism (5-HTTLPR). Alcohol-dependent subjects were hypothesized to show a decreased number of bindings sites and a lower dissociation constant. 5-HTTLPR S-genotype carriers in both alcohol-dependent and control subjects were expected to show significantly fewer binding sites and a lower dissociation constant. Influences of impulsive traits, chronic daily alcohol intake, duration of alcohol dependence, age of onset and age on [3H]paroxetine binding were also investigated. Inpatients meeting DSM IV alcohol dependence criteria and of German descent were recruited to avoid ethnic stratification effects. One hundred and seventeen control subjects of similar social status were recruited from a town community. Blood samples were taken from both alcohol-dependent and control subjects to determine 5-HTTLPR genotypes using PCR of lymphocyte DNA, and to perform platelet [3H]paroxetine binding (binding capacity: B(max); and dissociation constant: K(D)). Impulsivity was assessed using the Barratt impulsiveness scale version 5 (BIS-5) in alcohol-dependent subjects only. Alcohol-dependent subjects were subdivided into low or high impulsivity groups using a median-split of the BIS-5 scale. The control group was slightly older than the alcohol-dependent group (not statistically significant). [3H]paroxetine binding was investigated in 72 control subjects and 72 patients, of which five patients met type 2 alcohol dependence criteria. Genotyping was carried out in all patients and control subjects. A significant influence of duration of alcohol dependence was found on the [3H]paroxetine binding K(D) but not B(max.) Neither alcohol-dependent nor control subjects showed any differences in B(max) or K(D). S-allele carriers did not show a decreased binding or lower dissociation constant. Furthermore, no significant interaction between B(max) and K(D) with either 5-HTTLPR genotype or impulsivity was revealed. This was the first study to investigate platelet [3H]paroxetine binding in alcohol-dependent and age-matched control subjects in relation to the 5-HTTLPR genotype. No differences concerning 5-HTTLPR-alleles were found in these groups Furthermore, no significant interaction between these parameters and impulsivity was shown in alcohol-dependent subjects. These results do not support previous results of altered [3H]paroxetine binding sites in alcohol-dependent subjects or 5-HTTLPR S-allele carriers. K(D) might be influenced by duration of alcohol dependence, but not sufficiently to yield differences between alcohol-dependent and control subjects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980326     DOI: 10.1016/s0165-1781(00)00190-6

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  18 in total

1.  Impaired platelet [3H]paroxetine binding in female patients with borderline personality disorder.

Authors:  N M K Ng Ying Kin; Joel Paris; George Schwartz; Hallie Zweig-Frank; Howard Steiger; N P V Nair
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

2.  Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.

Authors:  Martin A Javors; Chamindi Seneviratne; John D Roache; Nassima Ait-Daoud; Susan E Bergeson; M Consuelo Walss-Bass; Fatema Z Akhtar; Bankole A Johnson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-11-04       Impact factor: 5.067

3.  Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?

Authors:  Bankole A Johnson; Martin A Javors; John D Roache; Chamindi Seneviratne; Susan E Bergeson; Nassima Ait-Daoud; Michael A Dawes; Jennie Z Ma
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-08-19       Impact factor: 5.067

4.  Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremens.

Authors:  Andre Tadic; Norbert Dahmen; Armin Szegedi; Dan Rujescu; Ina Giegling; Gabriele Koller; Ion Anghelescu; Christoph Fehr; Christoph Klawe; Ullrich W Preuss; Thomas Sander; Mohammad R Toliat; Peter Singer; Brigitta Bondy; Michael Soyka
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-19       Impact factor: 5.270

5.  Serotonin transporter gene promoter polymorphism (5-HTTLPR) and alcohol use in general population: interaction effect with birth cohort.

Authors:  Mariliis Vaht; Liis Merenäkk; Jarek Mäestu; Toomas Veidebaum; Jaanus Harro
Journal:  Psychopharmacology (Berl)       Date:  2014-01-10       Impact factor: 4.530

Review 6.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

7.  The 5-HTTLPR polymorphism, platelet serotonin transporter activity and platelet serotonin content in underweight and weight-recovered females with anorexia nervosa.

Authors:  Stefan Ehrlich; Leonora Franke; Susann Scherag; Roland Burghardt; Regina Schott; Nora Schneider; Simone Brockhaus; Jakob Hein; Ralf Uebelhack; Ulrike Lehmkuhl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-03       Impact factor: 5.270

Review 8.  Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Authors:  Deepika Suri; Cátia M Teixeira; Martha K Caffrey Cagliostro; Darshini Mahadevia; Mark S Ansorge
Journal:  Neuropsychopharmacology       Date:  2014-09-02       Impact factor: 7.853

9.  A review of 5-HT transporter linked promoter region (5-HTTLPR) polymorphism and associations with alcohol use problems and sexual risk behaviors.

Authors:  Muni Rubens; Venkataraghavan Ramamoorthy; Jennifer Attonito; Anshul Saxena; Sandeep Appunni; Nancy Shehadeh; Jessy G Dévieux
Journal:  J Community Genet       Date:  2015-09-04

10.  Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetron.

Authors:  Bankole A Johnson; Chamindi Seneviratne; Xin-Qun Wang; Nassima Ait-Daoud; Ming D Li
Journal:  Am J Psychiatry       Date:  2013-09       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.